(Clearwater Fl) Children of God for Life announced today that a new flu vaccine, Flucelvax produced by Novartis uses a morally produced mammal-based cell line rather than chick embryo. The proprietary cell line called MDCK (Madin Darby Canine Kidney) has been used for decades in vaccine production and offers a moral alternative to aborted fetal cell line flu vaccines that are currently under development by competing manufacturers.
“We are extremely pleased to see Novartis advance in the market over those such as Sanofi Pasteur who are developing influenza vaccines using aborted fetal cell lines,” said Children of God for Life Executive Director Debi Vinnedge. “Novartis built its new facility in Holly Springs NC focusing on a moral cell line and they are to be commended for listening to public concerns.”
Novartis, along with several pharmaceutical companies had taken license in early 2001 to aborted fetal cell line PER C6 and there was public concern that this cell line would replace the current and slower techonology of using chick embryo to produce influenza and H1N1 vaccines.
But Novartis changed direction and unlike some of its competitors chose the option of using a tested and safe mammal cell line that would not infringe on moral concerns. Vinnedge says she is thrilled they are the first to bring the new technology to market.
“We have been watching this closely for the past 10 years,” noted Vinnedge. “We encourage the pubic to write Novartis to congratulate and thank them for their new Flucelvax vaccine that will not force anyone to violate their religious and prolife beliefs.”
Contact Novartis through their contact link on the website at: http://www.novartisvaccines.com/us/index.shtml or at:
Novartis Corporation Corporate Communications
230 Park Avenue, 21st Floor
New York, NY 10169
Futher reading:
http://www.novartis.com/newsroom/media-releases/en/2012/1659272.shtml
Novartis receives FDA approval for Flucelvax®, the first cell-culture vaccine in US to help protect against seasonal influenza
- Cell-culture technology, an alternative to traditional egg-based production, is the most significant advancement in influenza vaccine manufacturing in more than 40 years[1]
- Flucelvax is the only influenza vaccine of its kind in the US and does not contain any preservatives, such as thimerosal, or antibiotics[2]
- Approval demonstrates Novartis leadership in advancing novel influenza vaccine research and manufacturing technologies
Thank you very much. I greatly appreciate your help and all the great work you do. God bless you all,…
Andrea, Paxlovid does not contain fetal cells. Aborted fetal cell lines were used in preclinical testing and were an essential…
I have Covid and my doctor has prescribed Paxlovid. I read that the development was compromised, but does the actual…
Chris, I sent a link to your email. You should have it shortly.
The link has disappeared. Where can I find the new updated ethical flu shot list for 2023-2024? Thank you.
Thank you kindly Jose for your help! Could you help me with one more …..Tamoxifen - for breast cancer? Does…
This is a reasonable rule of thumb, but there are exceptions. The poliomyelitis and rubella vaccines are examples of exceptions.…
Yvie, there is no comprehensive list, and this is due to the sheer number of approved drugs that are available.…
So, is it safe to say that if a medication is FDA approved before 1977 when fetal cell lines started…
Is there a list of medications that are abortion tainted? I'm in severe pain with fibromyalgia and am trying to…
Virginia, I have researched the development history of this drug and found no association with aborted fetal cell lines or…
Cefalexin was developed in 1967. This places its development prior to the advent of fetal cell lines in medical research.…
Do you have any information about the ethical status of Cephalexin (Keflex). If it is deemed unethical, then what is…
Is Aflibercept (Eylea) injection for Age related Macular Degeneration produced with or from human fetal cell lines?
Thank you, I came specifically looking for this information about nirsevimab.